Results 211 to 220 of about 96,906 (352)

Impact of haemoglobinA1c on platelet reactivity and cardiovascular outcomes in patients undergoing drug-eluting stent implantation. [PDF]

Sci Rep
Wu Y, Jiang X, Jiang L, Ji H, Liu M, Li W.   +5 more
europepmc   +1 more source

Implication of diabetic status on platelet reactivity and clinical outcomes after drug-eluting stent implantation: results from the PTRG-DES consortium. [PDF]

Cardiovasc Diabetol, 2023
Jeon KH, Jeong YH, Chae IH, Kim BK, Joo HJ, Chang K, Park Y, Song YB, Ahn SG, Lee SY, Cho JR, Her AY, Kim HS, Kim MH, Lim DS, Shin ES, Suh JW, PTRG-DES Consortium Investigators.   +17 more
europepmc   +1 more source

Inhibition of collagen-induced platelet reactivity by DGEA peptide.

, 2003
Bogusława Luzak, Jacek Golański, M. Różalski, Magdalena Boncler, Cezary Watała   +4 more
openalex   +2 more sources

A new nonhydrolyzable reactive cGMP analogue, (Rp)-guanosine-3′,5′-cyclic-S-(4-bromo-2,3-dioxobutyl)monophosphorothioate, which targets the cGMP binding site of human platelet PDE3A [PDF]

, 2008
Su H. Hung, Andy H. Liu, Robin A. Pixley, Penelope Francis, LaTeeka D. Williams, Christopher M. Matsko, Karine D. Barnes, Sharmila Sivendran, Roberta F. Colman, Robert W. Colman   +9 more
openalex   +1 more source

Mesoporous Gold Nanospheres Confined Platinum Nanoclusters as Robust ROS and Oxygen Nanogenerators for NIR‐II Hyperthermia Cancer Therapy

Advanced Science, EarlyView.
Mesoporous gold nanospheres confined platinum nanoclusters (MGNSs@Pt) is developed as robust hydroxyl radical and oxygen nanogenerators for multimodal therapies. Their NIR‐II LSPR property also allowed MGSNs to be ideal phototheranostic agents. The chemodynamic and photothermal therapy efficiently induced the tumor cell apoptosis, enabling the MGNSs@Pt
Fei Cun, Jie Chen, Hanxue Li, Yufang Kou, Meiyan Wang, Xiaomin Li, Hui Chen, Jilie Kong   +7 more
wiley   +1 more source

TRAP-Induced Platelet Reactivity Is Inhibited by Omega-3 Fatty Acid-Derived Prostaglandin E3 (PGE3). [PDF]

Biomedicines
Osete JM, García-Candel F, Fernández-Gómez FJ, Blanquer M, Atucha NM, García-Estañ J, Iyú D.   +6 more
europepmc   +1 more source

Corrigendum: The association between higher FFAs and high residual platelet reactivity among CAD patients receiving clopidogrel therapy. [PDF]

Front Cardiovasc Med, 2023
Zhao Z, Dong S, Sun T, Han K, Huang X, Ma M, Yang S, Zhou Y.   +7 more
europepmc   +1 more source

Increased CD40 ligand, C-reactive protein, and platelet-monocyte binding in patients with type 1 diabetes mellitus

, 2003
Scott A. Harding, Andrew J. Sommerfield, Jaydeep Sarma, Patrick J. Twomey, David E. Newby, Brian M. Frier, Keith A.A. Fox   +6 more
openalex   +1 more source

'A threshold of platelet reactivity for ischaemic events?' and 'The optimal threshold of high post-treatment platelet reactivity could be defined by a point-of care VerifyNow P2Y12 assay': reply [PDF]

, 2008
Matthew J. Price
openalex   +1 more source

Red Blood Cell Membrane Lipidomics: Potential Biomarkers Detecting Method for Plasma Volume Overload and Major Adverse Cardiovascular Events in Chronic Heart Failure Patients

Advanced Science, EarlyView.
A novel RBC indicator, ESI, is better than the traditional RBC indicators and is associated with CHF prevalence and in‐hospital death. RBC membrane lipidomics, Cer 18:0;O2/16:0, and LPE 18:0, are associated with plasma volume overload and MACE in CHF patients, but these plasma lipids could not.
Lin Zhang, Xiangqin Ou, Jingyi Lin, Xiaofei Luo, Jiashun Zhou, Xingyue Zhou, Peihua Zhao, Li Liu, Ziran Zhao, Ying Zhou, Guanwei Fan, Lifeng Han, Xiumei Gao   +12 more
wiley   +1 more source